Huge breakthrough for oncology as scientists nail lung-cancer gene
For 40 years researchers have tried to block a mutant gene. They’ve now done so with a drug the FDA has approved
30 May 2021 - 19:47
Amgen’s lung-cancer treatment sotorasib has won approval from US regulators, becoming the first therapy to target a tumour-stoking genetic mutation scientists have tried to block for decades...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
This article is free to read if you sign up or sign in.
If you have already registered or subscribed, please sign in to continue.
Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.